Skip to main content
  • Cancer
    Cancer is a group of diseases characterised by out-of-control cell growth. There are more than 100 different types of cancer. The cancer is named after the area of the body or organ where it originates.
Submitted by Dr S. Patel on 1 June 2014

Cancer is a group of diseases characterised by out-of-control cell growth. There are more than 100 different types of cancer. The cancer is named after the area of the body or organ where it originates. For example, if the cancer starts in the breast and spreads elsewhere, it is still called breast cancer.

Cancer occurs when the body’s normal cell division and regeneration process goes awry. Normal cells in the body follow a sequence of events - growth, division and death. This programmed cell death is called apoptosis. In cancer, this process breaks down and cells do not experience programmed death. This leads to out-of-control cell growth and division to form a mass of abnormal cells, ie, a tumour.

All tumours are not cancerous and all cancers do not form tumours. One example is leukaemia, which is cancer of the bone marrow.

Tumours can be categorised as:

  • Benign tumour
  • Malignant tumour

Tumours are called benign when they remain localised. Benign tumors are not cancerous and cells from such tumours do not spread to other parts of the body. Benign tumours are easy to remove by local surgery.

Malignant tumours are cancerous and grow faster than benign tumours. They can invade and destroy adjacent structures and spread to distant sites. The spreading of cancer is called metastasis.

Cancer cells spread because they do not make the substance that normal cells secrete to make them stick together. Thus, cancer cells float through the blood stream or lymphatic system to affect other parts of the body. This is called metastatic cancer, ie, cancer that has spread from its place of origin to affect another part of the body. However, the name of the cancer remains the same. If breast cancer spreads to the liver, it is metastatic breast cancer, not liver cancer.

Community
Condition

Stories

  • Esophageal Cancer Made Swallowing Of Even Ice Cream Hard
    When Mr. Sudhir Waghmare, 58, PhD, entrepreneur and innovator, was diagnosed with esophageal cancer he took it in his stride quite stolidly. What broke him down was the loss during chemotherapy of his luscious hair which he dearly cherished. He shares his personal narrative. My background I am an entrepreneur and innovator of a company engaged in manufacturing new born life saving devices since the last 31 years. I have a PhD degree in Neonatal Intensive care equipment. I am married to…
  • मैं कैंसर से नहीं मरूंगी
    मुंबई की 56 वर्षीय रश्मि सचदे को 15 साल पहले गैस्ट्रोइंटेस्टाइनल स्ट्रोमल ट्यूमर (जीआईएसटी) का निदान मिला था। वे कैंसर को एक पेइंग गेस्ट की तरह मानती हैं और अपनी कैंसर यात्रा को अपनी आस्था और हँसते रहने की प्रवृत्ति के सहारे संभालती हैं। 2004 की बात है।, मैंने देखा कि मेरा पेट फूलने लगा था और जब मैं सोने के लिए लेटती तो विशेष रूप से एक तरफ बहुत सख्त लगता। मुझे उस समय फूले हुए पेट के अलावा कोई अन्य स्वास्थ्य संबंधी शिकायत नहीं थी – पर पेट इतना फूला रहता कि लोग पूछने लगे कि क्या मैं गर्भवती हूं।…
  • Profile picture of Uday Kerwar Bladder cancer survivor and Ostomy India Chairperson framed in a blue background with the bladder cancer tricolour ribbon
    You Adapt To The Bladder Bag Like You Do To Eye-Glasses
    Uday Kerwar, survivor of stage 4 bladder cancer and currently Chairman of Ostomy Association of India (OAI) talks about his journey with bladder cancer, urostomy bags, its many challenges and plenty of adjustments before it becomes a part of you. Please tell us a little about yourself.  I am 62 and retired. Since 2016 I am continuously associated with Ostomy Association of India (OAI), a Charitable Trust providing rehabilitative support to people who have undergone Ostomy (life-saving…
  • Head shot of a bespectacled woman wearing a black and red dress and red necklace
    मेरे ब्रेन ट्यूमर के निदान ने मुझे बोल्ड बना दिया
    जब बेंगलुरु की 38 वर्षीया ए चित्रा को सीज़र होने लगे, तो शुरू में उनका एपिलेप्सी (मिर्गी) के लिए इलाज किया गया, लेकिन अंततः उन्हें मैलिग्नेंट ग्लियोमा (एक प्रकार का ब्रेन ट्यूमर) का निदान मिला। वे बताती हैं कि कैसे उन्होंने डॉक्टरों, परिवार, दोस्तों और अपनी कंपनी की टीम के समर्थन से अपनी बीमारी के उपचार और भावनात्मक पीड़ा को संभाला। कृपया हमें अपनी स्थिति के बारे में कुछ बताएं मुझे एनाप्लास्टिक एस्ट्रोसाइटोमा ग्रेड 3 नामक ब्रेन ट्यूमर का निदान मिला था। यह एक दुर्लभ, मैलिग्नेंट ट्यूमर है जिसे…
  • ब्रेन ट्यूमर होने के बाद मेरी पहली प्राथमिकता मेरा स्वास्थ्य है
    30 वर्षीय मेल्विन जॉर्ज इस लेख में एस्ट्रोसाइटोमा (एक प्रकार का ब्रेन ट्यूमर) का निदान प्राप्त करने, देखभाल के विकल्पों का आकलन करने और निर्णय लेने, और कैंसर के उपचार और सम्बंधित दुष्प्रभाव पर चर्चा करते हैं और साझा करते हैं  कि इन सब अनुभव और चुनौतियों ने उन्हें व्यक्तिगत रूप से कैसे प्रभावित किया और रिकवरी में उनकी आस्था उनका मुख्य सहारा कैसे बनी रही।  चौंकाने वाला निदान 11 जुलाई 2017 का दिन। मैं अपने छात्रावास के कमरे में अपने बिस्तर पर लेटा हुआ था और जैसे ही मैं जाका, मैंने देखा…
  • The author, a woman in a red and yellow sari and a yellow blouse, holding birds
    मैंने अपनी आवाज पैसिव स्मोकिंग (निष्क्रिय धूम्रपान) के कारण खो दी
    धूम्रपान न करने वाली 72 वर्षीया नलिनी सत्यनारायण को 10 साल पहले उनके घर में सेकेंड हैंड धुएं के संपर्क में आने के कारण गले (वॉयस बॉक्स) के कैंसर का निदान मिला। आज, उत्तरजीवी के रूप में, वे एक ऊर्जावान तंबाकू नियंत्रण योद्धा बन गई हैं और ऐसे लोगों को परामर्श देती हैं जिन्होंने स्वरयंत्र (लैरिन्क्स) की सर्जरी करवाई है जिसमें उनका वॉयस बॉक्स हटाया गया है - वे उन्हें कृत्रिम वॉयस बॉक्स से बात करना सिखाती हैं। आपने कब और कैसे अपने गले की समस्या को पहचाना? जनवरी 2010 की बात है। मुझे लगा कि मेरा गला…
  • Should Time Toxicity Be A Factor In Informed Decision Making?
    Patients with advanced cancers often contemplate the time burden of their cancer care. What does this exactly entail? Dr Arjun Gupta, an Oncologist and Researcher, recently wrote a paper about Time Toxicity for Cancer patients. He helps us understand this new concept and how it can affect quality of life for patients. What is ‘’time toxicity’’? We have seen tremendous progress in oncology in the past few decades. Yet, for advanced solid cancers, average survival benefits offered by new…
  • Webinar: Ovarian Cancer Awareness and Management
    This webinar is not just for Ovarian Cancer survivors but also for survivors of breast cancer, uterine cancer, colorectal cancer and all women at risk of Ovarian Cancer. Ovarian Cancer is a difficult to diagnose cancer. So it is very important for us to be aware of the surprising symptoms of Ovarian cancer. We must also know the factors that increase risk. Additionally, in COVID times, it is important to understand how to continue treatment and when you should vaccinate. We bring together a…
  • A panel discussion on Kidney Cancer with the profile pictures of the panelists
    Demystifying Kidney Cancer : Key Webinar takeaways
    Renal cell carcinoma is the most common type of adult kidney cancer, making up about 85% of diagnoses. And yet it is rarely talked about.  Kidney Cancer is also an area which has seen significant progress in treatment options. Key takeaways from the webinar are given below.  An expert panel talked about kidney cancer and answered questions and concerns that patients have. The panelists are Dr. KL Jayakumar, MD Radiation Oncology. Professor and HOD, Sreemookambika Cancer center,…
  • Webinar: Towards Patient Centred Access To Quality Cancer Care - Challenges
    PatientsEngage and EHA Consortium invite you to an interactive webinar series on Patient Centred Access to Quality Cancer Care. In the first of the series aligned to the UICC theme of "Close the Care Gap", we are very privileged to have an esteemed and diverse panel who will highlight the challenges faced in equitable access to quality cancer care and identify the areas where we still need to make progress. The panelists are Dr. CS Pramesh, Director Tata Memorial Hospital; Convener National…